食品伙伴網(wǎng)訊 2025年2月28日,歐盟食品安全局就一種食品酶非還原端α-l-阿拉伯呋喃糖苷酶(non-reducing end α-l-arabinofuranosidase)的安全性評價發(fā)布意見。
據(jù)了解,這種食品酶是由非轉(zhuǎn)基因塔賓曲霉菌株ARF生產(chǎn)的,旨在用于7種食品生產(chǎn)過程。
經(jīng)過評估,專家小組得出結(jié)論,這種食品酶在預(yù)期使用條件下不會引起安全問題。部分原文報道如下:
The food enzyme non-reducing end α-l-arabinofuranosidase (α-l-arabinofura-noside non-reducing end α-l-arabinofuranosidase, EC 3.2.1.55) is produced with the non-genetically modified Aspergillus tubingensis strain ARF by DSM Food Specialties B.V. A safety evaluation of this food enzyme was made previously, in which EFSA concluded that this food enzyme did not give rise to safety concerns when used in five food manufacturing processes. Subsequently, the applicant requested to extend its use to include two additional processes. In this assessment, EFSA updated the safety evaluation of this food enzyme when used in a total of seven food manufacturing processes. The dietary exposure was calculated to be up to 0.458 mg total organic solids (TOS)/kg body weight (bw) per day in European populations. When combined with the no observed adverse effect level previously reported (234 mg TOS/kg bw per day, the highest dose tested), the Panel derived a margin of exposure of at least 511. based on the new data, the revised margin of exposure and the previous evaluation, the Panel concluded that this food enzyme does not give rise to safety concerns under the revised intended conditions of use.
本文由食品伙伴網(wǎng)食品資訊中心編輯,供網(wǎng)友參考,有任何疑問,請聯(lián)系news@foodmate.net。
相關(guān)政策解讀
